J&J filed a lawsuit Tuesday in the US District Court for the District of Columbia alleging the US Health Resources and ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study ... and business fronts,” said Stephen Brady, ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello everyone, and welcome to the Mirum Pharmaceuticals’ Third ...

In August, Trump said he wouldn't rule out taking away access to mifepristone, which was also mentioned by the policy ...

Welcome to the Lisata Therapeutics' Third Quarter 2024 Financial Results and Business Update Conference Call ... Beyond our strategic clinical development plan, we have focused on optimizing our ...

The Mediterranean diet is a healthy eating plan based on the cultures of Mediterranean countries. It includes beverages such ...

AstraZeneca said it is doubling down on its investment in its U.S. business, a move that comes just one week ... includes ...

Dropshipping makes it simple to sell products online without investing a lot of money. When managed well, it can help you ...

Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...